Paper · 39167668
Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1 Diabetes: Report of Diabetes Mellitus Interagency Coordinating Committee Workshop.
Greenbaum CJ and 6 others. Diabetes, 2024. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1 Diabetes: Report of Diabetes Mellitus Interagency Coordinating Committee Workshop. Papers, record 39167668. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39167668
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1 Diabetes: Report of Diabetes Mellitus Interagency Coordinating Committee Workshop.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 1 | Major topic |
| Humans | |
| United States | |
| Mass Screening | |
| Antibodies, Monoclonal, Humanized |
Source PubMed
Grants23
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 DK085476 | NIDDK NIH HHS | United States | U01DK085476 | PubMed and NIH | NIH RePORTER |
| U01 DK061010 | NIDDK NIH HHS | United States | U01DK061010 | PubMed and NIH | NIH RePORTER |
| UM1 AI109565 | NIAID NIH HHS | United States | UM1AI109565 | PubMed and NIH | NIH RePORTER |
| UM1AI109565 | National Institute of Allergy and Infectious Diseases | UM1AI109565 | PubMed and NIH | NIH RePORTER | |
| U01 DK103282 | NIDDK NIH HHS | United States | U01DK103282 | PubMed and NIH | NIH RePORTER |
| UC4 DK106993 | NIDDK NIH HHS | United States | UC4DK106993 | PubMed and NIH | NIH RePORTER |
| U01 DK061042 | NIDDK NIH HHS | United States | U01DK061042 | PubMed and NIH | NIH RePORTER |
| U01 DK085509 | NIDDK NIH HHS | United States | U01DK085509 | PubMed and NIH | NIH RePORTER |
| UC4 DK117009 | NIDDK NIH HHS | United States | UC4DK117009 | PubMed and NIH | NIH RePORTER |
| U01 DK085466 | NIDDK NIH HHS | United States | U01DK085466 | PubMed and NIH | NIH RePORTER |
1 to 10 of 23
See all 23 grantsTrials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23,780,460 | Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. | JAMA | 2013 | https://conductscience.org/library/papers/23780460 | PubMed |
| 2 | 30,089,716 | β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis. | JCI Insight | 2018 | https://conductscience.org/library/papers/30089716 | PubMed |
| 3 | 18,650,369 | Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1. | Diabetes Care | 2008 | https://conductscience.org/library/papers/18650369 | PubMed |
| 4 | 30,002,199 | A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. | Diabetes Care | 2018 | https://conductscience.org/library/papers/30002199 | PubMed |
| 5 | 30,012,675 | Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes. | Diabetes Care | 2018 | https://conductscience.org/library/papers/30012675 | PubMed |
| 6 | 35,316,839 | Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective. | Diabetes | 2022 | https://conductscience.org/library/papers/35316839 | PubMed |
| 7 | 19,940,299 | Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19940299 | PubMed |
| 8 | 33,658,358 | Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/33658358 | PubMed |
| 9 | 37,708,415 | Hydroxychloroquine in Stage 1 Type 1 Diabetes. | Diabetes Care | 2023 | https://conductscience.org/library/papers/37708415 | PubMed |
| 10 | 37,607,392 | Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function. | Diabetes Care | 2023 | https://conductscience.org/library/papers/37607392 | PubMed |
1 to 10 of 49
See all 49 referencesCited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,974,164 | T cells in type 1 diabetes: mechanisms of β-cell autoimmunity, innate-adaptive immune crosstalk, and translational immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42974164 | PubMed |
| 42,589,969 | Reducing Diabetic Ketoacidosis in Pediatric Type 1 Diabetes: The Impact of Screening Programs and Early Disease-Modifying Treatment. | J Clin Med | 2026 | https://conductscience.org/library/papers/42589969 | PubMed |
| 41,221,484 | Latest Updates in Prevention and Screening of Type 1 Diabetes Mellitus. | Curr Pediatr Rep | 2025 | https://conductscience.org/library/papers/41221484 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39167668
GET https://conductscience.org/api/papers/v1/39167668/grants?page=2